Intrepid Potash (IPI) Returns To TTM Profitability Challenging Bearish Earnings Narratives
Intrepid Potash, Inc. IPI | 0.00 |
Intrepid Potash (IPI) closed out FY 2025 with Q4 revenue of US$59.7 million and a small net loss of US$0.4 million, translating to basic EPS of a US$0.03 loss, while the trailing twelve months show net income of US$11.2 million and EPS of US$0.86. Over recent quarters the company has seen revenue shift from US$44.6 million in Q4 2024 to US$76.8 million in Q1 2025, US$57.3 million in Q2, US$44.0 million in Q3, and US$59.7 million in Q4 2025, alongside EPS moving from a US$16.04 loss in Q4 2024 to quarterly profits between US$0.25 and US$0.36 before the modest Q4 loss. For investors, the headline is that margins have swung back into positive territory on a twelve month view, even as the latest quarter highlights that profitability is still sensitive to swings in underlying performance.
See our full analysis for Intrepid Potash.With the headline results set, the next step is to see how these numbers line up with the most widely shared narratives about Intrepid Potash, and where the fresh data challenges those views on growth, risks, and profitability.
Trailing US$11.2m profit masks past 5 year EPS contraction
- On a trailing twelve month basis Intrepid Potash reported net income of US$11.2m and EPS of US$0.86, while the five year earnings growth rate in the dataset is an annual decline of 53.9%.
- What stands out for a cautiously bullish view is that recent quarterly results show positive EPS in three of the last four quarters, yet
- Q1 to Q3 2025 delivered basic EPS between US$0.25 and US$0.36 with net income between US$3.3m and US$4.6m, but Q4 swung to a small loss of US$0.4m.
- The move to a trailing profit sits against the longer term 53.9% annual contraction in earnings, so any bullish stance hinges on whether the recent US$11.2m profit is repeatable rather than a short streak against a weaker history.
Revenue holds near US$238m while outlook points to slight 0.3% annual decline
- Trailing twelve month revenue sits at US$237.8m, and the provided outlook characterizes revenue as expected to decline modestly by 0.3% per year over the next three years.
- Critics focusing on a bearish angle highlight that the quarterly top line has moved between US$44.0m and US$76.8m in 2025. This
- Q1 2025 revenue of US$76.8m is the high point in the recent run, compared with US$44.0m in Q3 and US$59.7m in Q4, which shows the business operating across a wide revenue range within one fiscal year.
- When that pattern is paired with a modelled 0.3% annual revenue decline, bears point to limited support for a strong growth story even though the trailing revenue level is close to US$238m.
P/E of 44.3x and DCF fair value of US$0.77 create valuation tension
- The stock trades on a trailing P/E of 44.3x against a peer average of 18.7x and a US Chemicals industry average of 29.5x, while the provided DCF fair value of US$0.77 per share sits far below the current share price of US$37.67.
- What is most challenging for a bullish framing is that this premium multiple comes at the same time as a major one off US$10.0m loss in the last twelve months and a modest revenue decline outlook, so
- The high P/E relative to peers and industry means a large part of the share price is tied to expectations that go beyond the recent US$0.86 trailing EPS.
- The gap between US$37.67 and the US$0.77 DCF fair value in the data, combined with the one off loss, gives valuation focused investors plenty to question about how much future improvement is already reflected in the price.
Next Steps
Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Intrepid Potash's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.
With sentiment in this article pulling in both cautious and optimistic directions, now is a good time to look through the numbers yourself and decide how the balance of risks and rewards sits for your portfolio. Then weigh that view against the 1 key reward and 1 important warning sign.
See What Else Is Out There
Between the 53.9% annual EPS contraction, volatile quarterly results, and a P/E of 44.3x against a low DCF fair value, the risk reward balance looks stretched.
If that mix of earnings pressure and a rich multiple makes you cautious here, it is worth checking stocks on the 44 high quality undervalued stocks that may offer a sturdier margin of safety at current prices.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
